Wis. Admin. Code Department of Safety and Professional Services SPS 10.02

Current through September 30, 2024

Section SPS 10.02 - Diagnostic pharmaceutical agents

(1) A licensed optometrist, authorized in accordance with ch. Opt 6, may use topical ocular diagnostic pharmaceutical agents to determine the visual efficiency of the human visual system, including refractive and functional abilities, or to diagnose the presence of ocular disease or ocular manifestations of system disease and other departures from normal.

(2) Diagnostic pharmaceutical agents include:

(a)Mydriatics.

1. Phenylephrine 2.5%.

2. Hydroxyamphetamine 1%.

(b)Cycloplegics.

1. Tropicamide 1%.

2. Cyclopentolate 1%.

(c)Topical anesthetics.

1. Benoxinate 0.4%.

2. Proparacaine 0.5%.

3. Tetracaine 0.5%.

4. Benoxinate 0.4% - Fluorescein 0.25% Combination.

(d)Dyes.

1. Fluorescein 0.25% - Benoxinate 0.4% Combination.

2. Rose Bengal.

(e)Miotics.

1. Dapiprazole HCl.

2. Pilocarpine 0.125%.

(f) Any drug or device that is used for an ophthalmic diagnostic purpose and that is the subject of a new drug application approved by the food and drug administration under section 505 (c) (1) of the federal food, drug and cosmetic act, 21 USC 355, as amended.

(g) Any drug or device that is used for an ophthalmic diagnostic purpose and that is generally exempt from the new drug application approval requirement contained in section 505 of the federal food, drug and cosmetic act, 21 USC 355, as amended.

Wis. Admin. Code Department of Safety and Professional Services SPS 10.02

Adopted by, CR 19-028: cr. Register January 2020 No. 769, eff. 2-1-20; s. 35.17 correction in (2) (e) 2. made under s. 35.17, Stats., Register January 2020 No. 769, eff. 2/1/2020